Breaking News, Collaborations & Alliances

Sanofi-Aventis, Roche Sign Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi-Aventis has signed an agreement with Roche concerning the production of shikimic acid by fermentation for Roche’s Tamiflu supply chain. Shikimic acid is the key raw material for the manufacture of Tamiflu’s active ingredient (oseltamivir). Under the terms of the agreement, Sanofi-Aventis will supply Roche exclusively with the shikimic acid obtained. The shikimic acid will be produced in the Saint-Aubin-les-Elbeuf plant in France. This site, covering 18 hectares, has a fermenta...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters